It’s a new year, and #LCSM Chat is transitioning to monthly chats. Our first chat is a collaborative chat across all cancer hashtag communities titled “Immunotherapy: What Patients Need to Know.” The discussion will cover all types of immunotherapy currently approved for treatment of any cancer.
Chat moderator Janet Freeman-Daily (@JFreemanDaily) will be joined by special guest Lisa Rezende (@LisaRezende1), a biology educator (Assistant Professor of Practice) on the Molecular and Cellular Biology faculty at the University of Arizona. Lisa is also a long-term volunteer cancer advocate with FORCE (Facing Our Risk of Cancer Empowered), a cancer previvor (BRCA1 mutation carrier), daughter of a long-term ovarian cancer survivor, and recent caregiver to her stepmother through her diagnosis, treatment and hospice for Stage IV inflammatory breast cancer.
Our discussion will focus on the following topics:
- T1: Why doesn’t the immune system prevent cancer?
- T2: What types of immunotherapy have been approved?
- T3: How can we tell if immunotherapy will work for my cancer?
- T4: What are the downsides of immunotherapy?
- T5: How can I find the right immunotherapy clinical trial for me?
Hope you will join members of the #LCSM, #BCSM, #BTSM, #GYNCSM, #MMSM, #AYACSM, and other cancer hashtag communities for this tweetchat on January 10, 2019, at 5pm Pacific, 8 pm Eastern. Please remember to include #LCSM in ALL your tweets so the other chat participants can see them. If you need a refresher on how to participate, read our primer on participating in the chat . Note that some tweetchat apps (like tchat.io) will not display tweets longer than 140 characters.
Once your take cancer cells out of a living body, the cancer cells die, right? So how researchers study cancer?
One way researchers study cancer is by using “cancer models.” Cancer models are clumps of living cancer cells that exist either in a lab dish (see image above), or in animal models such as mice. Sometimes these models also include other living cells from the host environment. It’s not exactly the same as studying a living cancer in its human host, but it does allow researchers time to study the biology of a cancer and test different treatments against it.
In our Thursday, November 29, 2018 #LCSM Chat, we’re going to talk about cancer models. Our moderator Janet Freeman-Daily (@JFreemanDaily)–who presented a poster about the ROS1 Cancer Model Project at AACR in April 2018–will lead our discussion using the following questions:
- T1: What are cancer models? What types of cancer models are currently used?
- T2: How are cell lines created, and how are they used in research?
- T3: How are Patient-Derived Xenograft (PDX) mice models made, and how are they used in research?
- T4: What are the advantages and disadvantages of the different types of cancer models?
- T5: Where can we learn more about cancer models and support research with cancer models?
Hope you will join us for this tweetchat on November 29 at 5pm Pacific, 8 pm Eastern. Please remember to include #LCSM in ALL your tweets so the other chat participants can see them. If you need a refresher on how to participate, read our primer on participating in the chat . Note that some tweetchat apps (like tchat.io) will not display tweets longer than 140 characters.
This work by Janet Freeman-Daily is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
On Thursday November 15, 2018, at 8 PM Eastern Time (5 PM Pacific Daylight Time), #LCSM Chat will hold an Open Mic Nite. We’ll be discussing Lung Cancer Awareness Month (#LCAM) and whatever additional lung cancer topics are foremost on our minds. Our moderator will be Janet Freeman-Daily (@JFreemanDaily). This would be a particularly good chat for those who are just starting with Twitter or tweet chats (please check out our tweetchat primer). Hope you’ll join us!